CD8A and neoplasm: Notably, despite these suppressive effects, immunotherapy regimens using anti–PD-1 alone or in combination with a cancer vaccine induced tumor rejection in both lean and obese mice and partially restored pro-inflammatory CD8+ T cell activity.